Abstract
Pulmonary hypertension in obstructive sleep apnea syndrome is common and under recognized. Although more common in patients with OSA associated with chronic lung disease, it is still present in about 20% of patient without co morbid lung or heart disease. Various pathophysiologic changes in OSA especially nocturnal oxygen desaturation, intrathoracic pressure swings, abnormalities in lung mechanics, alteration in ventricular function and rheological changes can contribute to the presence and severity of pulmonary hypertension. The clinical profile in individuals with OSA and pulmonary hypertension are different than in patients with OSA who do not have pulmonary hypertension. Effective treatment of OSA with n CPAP for 12 weeks results in improvement in pulmonary artery pressure.
Keywords: Sleep and pulmonary hypertension, OSA and pulmonary hypertension, sleep and pathophysiology in pulmonary hypertension, CPAP and pulmonary hypertension
Current Respiratory Medicine Reviews
Title: Sleep in Pulmonary Hypertension
Volume: 5 Issue: 4
Author(s): Siva Ramachandran
Affiliation:
Keywords: Sleep and pulmonary hypertension, OSA and pulmonary hypertension, sleep and pathophysiology in pulmonary hypertension, CPAP and pulmonary hypertension
Abstract: Pulmonary hypertension in obstructive sleep apnea syndrome is common and under recognized. Although more common in patients with OSA associated with chronic lung disease, it is still present in about 20% of patient without co morbid lung or heart disease. Various pathophysiologic changes in OSA especially nocturnal oxygen desaturation, intrathoracic pressure swings, abnormalities in lung mechanics, alteration in ventricular function and rheological changes can contribute to the presence and severity of pulmonary hypertension. The clinical profile in individuals with OSA and pulmonary hypertension are different than in patients with OSA who do not have pulmonary hypertension. Effective treatment of OSA with n CPAP for 12 weeks results in improvement in pulmonary artery pressure.
Export Options
About this article
Cite this article as:
Ramachandran Siva, Sleep in Pulmonary Hypertension, Current Respiratory Medicine Reviews 2009; 5 (4) . https://dx.doi.org/10.2174/157339809790112474
DOI https://dx.doi.org/10.2174/157339809790112474 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Animal Models of Carcinogenesis in Inflamed Colorectum: Potential Use in Chemoprevention Study
Current Drug Targets Multi-Target Profile of Oleocanthal, An Extra-Virgin Olive Oil Component
Current Bioactive Compounds Prevention of Postprandial Metabolic Stress in Humans: Role of Fruit- Derived Products
Endocrine, Metabolic & Immune Disorders - Drug Targets Targeting Monoamine Oxidases with Multipotent Ligands: An Emerging Strategy in the Search of New Drugs Against Neurodegenerative Diseases
Current Medicinal Chemistry Cardiovascular and Renal Complications of Type 2 Diabetes in Obesity:Role of Sympathetic Nerve Activity and Insulin Resistance
Current Diabetes Reviews Targeted Therapy Options for Treatment of Bone Metastases; Beyond Bisphosphonates
Current Pharmaceutical Design Menopause and its Cardiometabolic Consequences: Current Perspectives
Current Vascular Pharmacology Pharmacometrics of Stilbenes: Seguing Towards the Clinic
Current Clinical Pharmacology Novel Anti-platelet Agents for the Treatment of Stable Angina Pectoris
Current Pharmaceutical Design Advanced Therapies For End-Stage Heart Failure
Current Cardiology Reviews The Biochemical Parameters and Vitamin D Levels in ICU Patients with Covid-19: A Cross-Sectional Study
Endocrine, Metabolic & Immune Disorders - Drug Targets Variation of Antioxidant Capacity in Different Layers of Onion (Allium cepa L.) At Two Different Stages of Maturation
Current Nutrition & Food Science Pulmonary Hypertension secondary to Left Heart Disease
Current Vascular Pharmacology Susceptibility Genes in Hypertension
Current Pharmaceutical Design New Class of Pyrimidinesulfamoyl Containing Pyrazole and Pyrrole Derivatives and Their Antioxidant Activity
Letters in Organic Chemistry Development of Conformational Mimetics of Conserved Streptococcus Pyogenes Minimal Epitope as Vaccine Candidates
Current Drug Delivery Interplay of Carotenoids with Cigarette Smoking: Implications in Lung Cancer
Current Medicinal Chemistry Current Therapeutics, Their Problems and Thiol Metabolism as Potential Drug Targets in Leishmaniasis
Current Drug Metabolism Metabolic Syndrome X is a Low-Grade Systemic Inflammatory Condition with its Origins in the Perinatal Period
Current Nutrition & Food Science One-Compound-Multi-Target: Combination Prospect of Natural Compounds with Thrombolytic Therapy in Acute Ischemic Stroke
Current Neuropharmacology